Rosemont Biotech Private Limited
About Rosemont Biotech Private Limited
Data last updated:
Rosemont Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 04 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC215236. Its GSTIN is 07AAFCR1815A1ZX (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rohit Chhillar and Saroj Chhillar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 16 Milap Nagar Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.47 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹29,014 (net margin 1%) and EBITDA of ₹1.89 Lakh (EBITDA margin 6.4%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rosemont Biotech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 16 Milap Nagar Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Rosemont Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rosemont Biotech is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Rosemont Biotech Private Limited, buy the company report.
Financials of Rosemont Biotech Private Limited
FY 2025 filings availableRosemont Biotech Private Limited reported revenue of ₹29.47 Lakh (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 29% fall in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29,014 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rosemont Biotech Private Limited, buy the company report.
Board of directors of Rosemont Biotech Private Limited
Rosemont Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Chhillar Also directs: Kshaar Herbals Private Limited | Director | 04 Mar 2011 | 15 Years 8 Months | Current |
| Saroj Chhillar | Additional Director | 01 May 2011 | 15 Years 6 Months | Current |
Peer comparison
Rosemont Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ismo Health Care Private Limited | ₹29.66 Lakh (FY 2023) | Chennai, Tamil Nadu, India | ||||
| Iera Start-Ups Private Limited | ₹29.52 Lakh (FY 2024) | 13.0% | Varanasi, Uttar Pradesh, India | |||
| Relieka Healthcare Private Limited | ₹29.51 Lakh (FY 2025) | -21.0% | Gurugram, Haryana, India | |||
| Agr Pharma India Private Limited | ₹29.5 Lakh (FY 2025) | -9.0% | Ghatkesar, Telangana, India | |||
| Medion Medical System Private Limited | ₹29.49 Lakh (FY 2025) | 2467.0% | Mumbai, Maharashtra, India | |||
| Rosemont Biotech Private Limitedthis company | ₹29.47 Lakh (FY 2024) | ₹29,014 | 1% | -29.0% | New Delhi, Delhi, India | |
| Digiswasthya Healthcare India Private Limited | ₹29.39 Lakh (FY 2025) | 10.0% | Nagar, Uttar Pradesh, India | |||
| Medi Sprouts India Private Limited | ₹29.33 Lakh (FY 2024) | -16.0% | Kochi, Kerala, India | |||
| Medisol Health India Private Limited | ₹29.31 Lakh (FY 2017) | 34.0% | Haripur Raipur, Rajasthan, India | |||
| Indianova Healthcare Private Limited | ₹29.31 Lakh (FY 2021) | -61.0% | Banglaore, Karnataka, India | |||
| Rogo Technologies Private Limited | ₹29.3 Lakh (FY 2024) | 16.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Rosemont Biotech Private Limited, buy the company report.
Auditor
Rosemont Biotech Private Limited is audited by GROVERANDASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GROVERANDASSOCIATES | FY 2017 | 023325N |
Shareholding
The shareholding of Rosemont Biotech Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rosemont Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rosemont Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rosemont Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rosemont Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCR1815A1ZX | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rosemont Biotech Private Limited, buy the company report.
Recent activity
Rosemont Biotech Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Poonam Chhillar ceased to be Director on 01 May 2011.
Frequently asked questions
Rosemont Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 04 March 2011 (15+ years old) and is registered under CIN U24232DL2011PTC215236.
Rosemont Biotech has 2 current directors:
- Rohit Chhillar - Director
- Saroj Chhillar - Additional Director
The latest financial statements of Rosemont Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rosemont Biotech is 07AAFCR1815A1ZX, registered in Delhi.
The CIN (Corporate Identification Number) of Rosemont Biotech is U24232DL2011PTC215236. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rosemont Biotech was incorporated on 04 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rosemont Biotech by revenue are Ismo Health Care Private Limited, Iera Start-Ups Private Limited, Relieka Healthcare Private Limited, Agr Pharma India Private Limited, Medion Medical System Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Poonam Chhillar ceased to be Director on 01 May 2011. Saroj Chhillar was appointed as Additional Director on 01 May 2011. Rohit Chhillar was appointed as Director on 04 Mar 2011.
The registered office of Rosemont Biotech is at F – 16 Milap Nagar Uttam Nagar, New Delhi, Delhi, India – 110059.
Rosemont Biotech operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Rosemont Biotech is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
